==== Front Front Neurol Front Neurol Front. Neurol. Frontiers in Neurology 1664-2295 Frontiers Media S.A. 10.3389/fneur.2023.1227084 Neurology Correction Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease Torrealba-Acosta Gabriel 1 2 * † Yu Eric 3 4 † Lobo-Prada Tanya 2 5 Ruíz-Martínez Javier 6 7 8 Gorostidi-Pagola Ana 7 8 9 Gan-Or Ziv 3 4 10 Carazo-Céspedes Kenneth 11 Trempe Jean-François 12 Mata Ignacio F. 13 Fornaguera-Trías Jaime 2 5 1Department of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, United States 2Neurosciences Research Center, Universidad de Costa Rica, San José, Costa Rica 3Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada 4Department of Human Genetics, McGill University, Montreal, QC, Canada 5Department of Biochemistry, Medicine School, Universidad de Costa Rica, San José, Costa Rica 6Group of Neurodegenerative Diseases, Biodonostia Health Research Institute, San Sebastian, Spain 7CIBERNED, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain 8Movement Disorders Unit, Neurology Department, Donostialdea Integrated Health Organisation, Osakidetza Basque Health Service, San Sebastian, Spain 9Genomic Platform, Biodonostia Health Research Institute, San Sebastian, Spain 10Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada 11Department of Neurology, Hospital San Juan de Dios, Caja Costarricense de Seguro Social, San José, Costa Rica 12Department of Pharmacology and Therapeutics and Centre de Recherche en Biologie Structurale, McGill University, Montreal, QC, Canada 13Cleveland Clinic Foundation, Genomic Medicine, Lerner Research Institute, Cleveland, OH, United States Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland *Correspondence: Gabriel Torrealba-Acosta gabriel.torrealbaacosta@bcm.edu †These authors have contributed equally to this work and share first authorship 15 6 2023 2023 15 6 2023 14 122708422 5 2023 01 6 2023 Copyright © 2023 Torrealba-Acosta, Yu, Lobo-Prada, Ruíz-Martínez, Gorostidi-Pagola, Gan-Or, Carazo-Céspedes, Trempe, Mata and Fornaguera-Trías. 2023 Torrealba-Acosta, Yu, Lobo-Prada, Ruíz-Martínez, Gorostidi-Pagola, Gan-Or, Carazo-Céspedes, Trempe, Mata and Fornaguera-Trías https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A corrigendum on Clinical and genetic analysis of Costa Rican patients with Parkinson's disease by Torrealba-Acosta, G., Yu, E., Lobo-Prada, T., Ruíz-Martínez. J., Gorostidi-Pagola. A., Gan-Or, Z., Carazo-Céspedes, K., Trempe, J.-F., Mata, I. F., and Fornaguera-Trías, J. (2021). Front. Neurol. 12:656342. doi: 10.3389/fneur.2021.656342 Parkinson's disease genotype phenotype Costa Rica Latin America section-at-acceptanceNeurogenetics ==== Body pmcIn the published article, there was an error. The stated number of protocols needed to be corrected. These errors were identified after an audit conducted by the CONIS (Consejo Nacional de Investigacion en Salud) of Costa Rica. A correction has been made to the Ethics Statement. This statement previously stated: The studies involving human participants were reviewed and approved by Ethics Committee of Hospital San Juan de Dios, Caja Costarricense de Seguro Social (CLOBI-HSJD #014- 2015) and the University of Costa Rica (837-B5-304). The patients/participants provided their written informed consent to participate in this study. The corrected statement appears below: The studies involving human participants were reviewed and approved by the Ethics Committee of the University of Costa Rica (VI-3668-2014 and final report 837-B5-302). The patients/participants provided their written informed consent to participate in this study. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.